LIFE-B:CA:TSX-Evolve Global Healthcare Enhanced Yield Fund UnHedged Units (CAD)

ETF | Others |

Last Closing

CAD 25.92

Change

-0.13 (-0.50)%

Market Cap

N/A

Volume

1.45K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 5.46B
XEQT:CA iShares Core Equity Portfolio

-0.14 (-0.42%)

CAD 5.15B
PHYS-U:CA Sprott Physical Gold Trust

+0.14 (+0.65%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.02 (-0.05%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.07 (-0.26%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

-0.22 (-1.89%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.04 (+0.18%)

CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

-0.16 (-0.32%)

CAD 2.59B

ETFs Containing LIFE-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.95% 41% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.95% 42% F 45% F
Trailing 12 Months  
Capital Gain 12.94% 35% F 36% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.94% 35% F 40% F
Trailing 5 Years  
Capital Gain 18.52% 45% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.52% 45% F 51% F
Average Annual (5 Year Horizon)  
Capital Gain 2.18% 52% F 44% F
Dividend Return 2.35% 53% F 38% F
Total Return 0.16% 65% D 18% F
Risk Return Profile  
Volatility (Standard Deviation) 5.54% 72% C 88% B+
Risk Adjusted Return 42.37% 65% D 55% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike